ANIDULAFUNGIN

ANIDULAFUNGIN was reported 1627 times

ANIDULAFUNGIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ABIOTROPHIA DEFECTIVA ENDOCARDITIS 4 0.4444
1 INTERFERON GAMMA RECEPTOR DEFICIENCY 1 0.3333
2 HIV INFECTION CDC GROUP I 1 0.3333
3 FLUID BALANCE POSITIVE 4 0.2667
4 PROTOTHECOSIS 23 0.2447
5 AORTOENTERIC FISTULA 13 0.2031
6 SPLENIC CANDIDIASIS 4 0.1739
7 GEOTRICHUM INFECTION 22 0.1043
8 INTRACRANIAL INFECTION 13 0.1040
9 SEPTAL PANNICULITIS 8 0.1000
10 BLADDER CANDIDIASIS 1 0.1000
11 LACTOBACILLUS BACTERAEMIA 2 0.0952
12 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY NEGATIVE 1 0.0909
13 ADRENERGIC SYNDROME 7 0.0864
14 FLUOROSIS 7 0.0814
15 URINE OUTPUT FLUCTUATION 2 0.0625
16 FUNGAL ENDOCARDITIS 18 0.0598
17 EUBACTERIUM INFECTION 1 0.0526
18 ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) 1 0.0526
19 HAEMOSTASIS 8 0.0491
20 MYCOTIC ENDOPHTHALMITIS 9 0.0476
21 SCEDOSPORIUM INFECTION 31 0.0439
22 EOSINOPHILIC PUSTULAR FOLLICULITIS 4 0.0430
23 INTRAOCULAR PRESSURE TEST 10 0.0417
24 PERIOSTITIS 18 0.0417
25 HEPATOSPLENIC CANDIDIASIS 6 0.0408
26 ABDOMINAL WOUND DEHISCENCE 11 0.0403
27 ENDOCARDITIS CANDIDA 3 0.0395
28 MORGANELLA INFECTION 11 0.0375
29 CAVERNOUS SINUS SYNDROME 1 0.0370
30 FUSARIUM INFECTION 24 0.0343
31 CEREBRAL CIRCULATORY FAILURE 2 0.0323
32 SEPTIC PULMONARY EMBOLISM 6 0.0308
33 ANASTOMOTIC INFECTION 1 0.0286
34 ANTINUCLEAR ANTIBODY NEGATIVE 1 0.0286
35 CUTANEOUS MUCORMYCOSIS 5 0.0272
36 TRICHOSPORON INFECTION 11 0.0272
37 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 6 0.0267
38 DISSEMINATED SPOROTRICHOSIS 1 0.0263
39 EYE INFECTION FUNGAL 10 0.0258
40 FIBRIN D DIMER DECREASED 1 0.0256
41 DISSEMINATED MUCORMYCOSIS 10 0.0254
42 THROMBOPHLEBITIS SEPTIC 5 0.0244
43 RECTAL PERFORATION 13 0.0241
44 BASAL GANGLIA HAEMATOMA 1 0.0238
45 LIVER GRAFT LOSS 1 0.0233
46 BRAIN STEM ISCHAEMIA 4 0.0223
47 PRIMARY MYELOFIBROSIS 7 0.0217
48 BLOOD PYRUVIC ACID INCREASED 1 0.0213
49 HERPES SIMPLEX HEPATITIS 5 0.0208
50 ASPARTATE AMINOTRANSFERASE 5 0.0205
51 GASTRIC ISCHAEMIA 1 0.0204
52 CARDIAC INDEX DECREASED 2 0.0194
53 FUNGAEMIA 30 0.0190
54 SYSTEMIC CANDIDA 46 0.0183
55 ANTI A ANTIBODY POSITIVE 1 0.0182
56 LIVER TRANSPLANT FAILURE 1 0.0182
57 ESCHERICHIA PERITONITIS 1 0.0182
58 INFECTION PROTOZOAL 1 0.0175
59 WOUND INFECTION FUNGAL 2 0.0164
60 SALPINGO-OOPHORITIS 2 0.0164
61 CANDIDA ENDOPHTHALMITIS 2 0.0164
62 BLOOD BETA-D-GLUCAN INCREASED 5 0.0163
63 AEROMONAS INFECTION 3 0.0159
64 TUBERCULOSIS GASTROINTESTINAL 5 0.0157
65 MEDIASTINAL SHIFT 1 0.0149
66 DISSEMINATED ASPERGILLOSIS 7 0.0148
67 CEREBRAL FUNGAL INFECTION 4 0.0141
68 HERPES SIMPLEX MENINGITIS 1 0.0141
69 CATHETER CULTURE POSITIVE 1 0.0141
70 CITROBACTER INFECTION 6 0.0140
71 PERITONEAL HAEMATOMA 2 0.0133
72 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 1 0.0132
73 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 3 0.0129
74 SCAR PAIN 5 0.0124
75 HYPOPERFUSION 13 0.0124
76 CARDIAC VALVE VEGETATION 6 0.0123
77 GASTROINTESTINAL MUCORMYCOSIS 2 0.0120
78 PURPURA FULMINANS 3 0.0118
79 MICROSCOPIC POLYANGIITIS 3 0.0116
80 HYPHAEMA 6 0.0115
81 CYTOMEGALOVIRUS HEPATITIS 4 0.0113
82 INFECTION IN AN IMMUNOCOMPROMISED HOST 8 0.0111
83 PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0111
84 ENTEROCOCCAL INFECTION 51 0.0105
85 PHAEOHYPHOMYCOSIS 5 0.0104
86 BACILLUS TEST POSITIVE 1 0.0101
87 PARVOVIRUS INFECTION 4 0.0099
88 HYPOGONADISM 10 0.0099
89 BRAIN ABSCESS 25 0.0099
90 PERIPHERAL CIRCULATORY FAILURE 4 0.0098
91 HYDROPNEUMOTHORAX 1 0.0097
92 LINEAR IGA DISEASE 16 0.0096
93 NEUTROPENIC INFECTION 9 0.0094
94 PSEUDOMONAL BACTERAEMIA 8 0.0094
95 HAEMORRHAGIC INFARCTION 5 0.0091
96 BLOOD LACTIC ACID ABNORMAL 1 0.0089
97 COLONIC FISTULA 5 0.0088
98 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 29 0.0088
99 PERFORATION 7 0.0087
100 SYSTEMIC MYCOSIS 10 0.0086
101 MALIGNANT PERITONEAL NEOPLASM 5 0.0085
102 KLEBSIELLA BACTERAEMIA 8 0.0084
103 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE 1 0.0084
104 SEVERE CUTANEOUS ADVERSE REACTION 2 0.0084
105 HEPATIC INFECTION FUNGAL 1 0.0083
106 IMMOBILISATION PROLONGED 1 0.0082
107 HAEMATOLOGICAL INFECTION 20 0.0082
108 BURKHOLDERIA TEST POSITIVE 1 0.0081
109 SPINAL CORD DISORDER 13 0.0079
110 ABDOMINAL COMPARTMENT SYNDROME 5 0.0078
111 PULMONARY MUCORMYCOSIS 4 0.0076
112 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 3 0.0074
113 CRYSTALLURIA 4 0.0074
114 ASYMPTOMATIC BACTERIURIA 1 0.0074
115 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
116 CANDIDA TEST POSITIVE 3 0.0072
117 HERNIAL EVENTRATION 1 0.0071
118 BILOMA 1 0.0071
119 VIRAL HAEMORRHAGIC CYSTITIS 5 0.0070
120 MUCORMYCOSIS 18 0.0069
121 HEPATIC ARTERY THROMBOSIS 2 0.0068
122 INFECTIOUS PLEURAL EFFUSION 10 0.0066
123 ENTHESOPATHY 10 0.0064
124 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
125 HERPES ZOSTER INFECTION NEUROLOGICAL 1 0.0063
126 CHORIORETINITIS 4 0.0062
127 ENTEROCOCCAL SEPSIS 5 0.0062
128 MULTIPLE ORGAN DYSFUNCTION SYNDROME 174 0.0061
129 CNS VENTRICULITIS 2 0.0061
130 HYPERMAGNESAEMIA 4 0.0061
131 GASTROINTESTINAL MUCOSAL DISORDER 4 0.0061
132 FUNCTIONAL GASTROINTESTINAL DISORDER 21 0.0061
133 FUNGAL SEPSIS 5 0.0060
134 INFECTIVE MYOSITIS 1 0.0060
135 GASTROINTESTINAL FUNGAL INFECTION 3 0.0058
136 IMPRISONMENT 10 0.0057
137 INTRACARDIAC MASS 1 0.0056
138 BASE EXCESS DECREASED 1 0.0056
139 METABOLIC ALKALOSIS 9 0.0056
140 GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0056
141 STAPHYLOCOCCAL BACTERAEMIA 24 0.0055
142 CANDIDA INFECTION 92 0.0054
143 RESPIRATORY GAS EXCHANGE DISORDER 2 0.0054
144 FUNGAL PERITONITIS 8 0.0053
145 HAEMODYNAMIC INSTABILITY 39 0.0051
146 CELLULITIS GANGRENOUS 1 0.0051
147 ECTHYMA 2 0.0050
148 HYPOCHROMIC ANAEMIA 5 0.0049
149 BLOOD UREA DECREASED 6 0.0048
150 WOUND INFECTION BACTERIAL 2 0.0048
151 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
152 INJECTION SITE PLAQUE 1 0.0048
153 ASPERGILLUS INFECTION 31 0.0047
154 GENITAL HERPES SIMPLEX 1 0.0047
155 DUODENAL POLYP 1 0.0047
156 STAPHYLOCOCCAL ABSCESS 3 0.0047
157 ACUTE ON CHRONIC LIVER FAILURE 1 0.0046
158 PATHOGEN RESISTANCE 42 0.0046
159 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
160 DEVICE RELATED SEPSIS 9 0.0045
161 BRONCHOPULMONARY ASPERGILLOSIS 34 0.0044
162 IMMUNE-MEDIATED PNEUMONITIS 1 0.0043
163 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
164 HERPES ZOSTER CUTANEOUS DISSEMINATED 1 0.0043
165 ANAPHYLACTOID SHOCK 2 0.0043
166 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 4 0.0042
167 ENTEROBACTER TEST POSITIVE 1 0.0041
168 SKIN NECROSIS 21 0.0040
169 SEPSIS SYNDROME 2 0.0040
170 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15 0.0039
171 TRACHEOBRONCHITIS 3 0.0039
172 BACTEROIDES INFECTION 1 0.0038
173 HUMAN POLYOMAVIRUS INFECTION 2 0.0038
174 PLACENTAL INSUFFICIENCY 3 0.0037
175 INTERVERTEBRAL DISCITIS 7 0.0037
176 RESPIRATORY ALKALOSIS 6 0.0037
177 STENOTROPHOMONAS INFECTION 5 0.0037
178 NEUROLOGICAL SYMPTOM 21 0.0037
179 ANTITHROMBIN III DECREASED 1 0.0037
180 RENAL ISCHAEMIA 2 0.0037
181 ACINETOBACTER INFECTION 4 0.0037
182 HYPERTENSIVE CARDIOMYOPATHY 1 0.0036
183 LUNG CONSOLIDATION 10 0.0036
184 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
185 GRAFT VERSUS HOST DISEASE 25 0.0035
186 OPHTHALMIC HERPES SIMPLEX 2 0.0035
187 PULMONARY SEPSIS 5 0.0034
188 PSEUDOMONAL SEPSIS 6 0.0034
189 PROCALCITONIN INCREASED 4 0.0034
190 ENTEROCUTANEOUS FISTULA 3 0.0034
191 DEVICE EMBOLISATION 1 0.0034
192 HYPERLACTACIDAEMIA 9 0.0034
193 DISSEMINATED INTRAVASCULAR COAGULATION 46 0.0033
194 ASPERGILLUS TEST POSITIVE 1 0.0032
195 MEAN CELL VOLUME DECREASED 5 0.0032
196 GRANULOCYTE COUNT DECREASED 6 0.0032
197 ACUTE PSYCHOSIS 8 0.0032
198 KLEBSIELLA INFECTION 16 0.0032
199 PARESIS 7 0.0031
200 HEPATIC INFECTION 4 0.0031
201 HYPERCHLORAEMIA 2 0.0031
202 BACTERAEMIA 37 0.0031
203 CANDIDA PNEUMONIA 1 0.0031
204 ENTEROCOCCUS TEST POSITIVE 2 0.0031
205 EPIDERMAL NECROSIS 3 0.0031
206 KLEBSIELLA TEST POSITIVE 2 0.0031
207 CONCOMITANT DISEASE PROGRESSION 6 0.0031
208 MULTI-ORGAN DISORDER 6 0.0030
209 SPUTUM ABNORMAL 2 0.0030
210 BACTERIAL PYELONEPHRITIS 1 0.0030
211 SEPTIC SHOCK 128 0.0029
212 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 1 0.0029
213 ISCHAEMIC HEPATITIS 4 0.0029
214 COVID-19 PNEUMONIA 34 0.0029
215 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
216 BRONCHIAL OBSTRUCTION 4 0.0028
217 CATHETER REMOVAL 1 0.0028
218 DRUG RESISTANCE 72 0.0028
219 RESPIRATORY ACIDOSIS 11 0.0028
220 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
221 BACTERIAL DISEASE CARRIER 2 0.0027
222 MEAN CELL HAEMOGLOBIN DECREASED 5 0.0027
223 DISSEMINATED TUBERCULOSIS 7 0.0027
224 WOUND HAEMORRHAGE 10 0.0027
225 RESPIRATORY TRACT OEDEMA 2 0.0027
226 CARDIAC INFECTION 2 0.0027
227 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 2 0.0027
228 ANISOCORIA 1 0.0026
229 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
230 BRONCHIAL DISORDER 4 0.0026
231 INTESTINAL ISCHAEMIA 14 0.0025
232 STUPOR 8 0.0025
233 LIVER ABSCESS 8 0.0025
234 PSEUDOMONAS INFECTION 21 0.0024
235 PSYCHIATRIC SYMPTOM 18 0.0024
236 SEPTIC EMBOLUS 2 0.0024
237 FISTULA OF SMALL INTESTINE 1 0.0024
238 PUPIL FIXED 4 0.0023
239 DRUG CLEARANCE DECREASED 3 0.0023
240 ACQUIRED GENE MUTATION 3 0.0023
241 PNEUMONIA FUNGAL 9 0.0023
242 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
243 DEGENERATIVE BONE DISEASE 1 0.0023
244 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
245 IMPLANT SITE HAEMORRHAGE 1 0.0023
246 BLOOD SODIUM INCREASED 6 0.0022
247 LOCALISED INTRAABDOMINAL FLUID COLLECTION 1 0.0022
248 PNEUMONIA KLEBSIELLA 4 0.0022
249 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
250 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
251 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 1 0.0021
252 ESCHERICHIA BACTERAEMIA 5 0.0021
253 BLOOD PHOSPHORUS ABNORMAL 1 0.0021
254 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0021
255 HEPATIC NECROSIS 8 0.0021
256 UTERINE RUPTURE 3 0.0021
257 WOUND DEHISCENCE 7 0.0021
258 INFECTIVE ANEURYSM 1 0.0020
259 GASTRITIS HAEMORRHAGIC 3 0.0020
260 SUSPECTED OFF LABEL USE 9 0.0020
261 ORGAN FAILURE 8 0.0020
262 ANURIA 17 0.0020
263 ABDOMINAL INFECTION 5 0.0020
264 PNEUMONIA PSEUDOMONAL 3 0.0020
265 MULTIPLE-DRUG RESISTANCE 6 0.0019
266 SMALL INTESTINAL STENOSIS 2 0.0019
267 PURULENT DISCHARGE 8 0.0019
268 STREPTOCOCCAL BACTERAEMIA 2 0.0018
269 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 4 0.0018
270 DRUG LEVEL BELOW THERAPEUTIC 10 0.0018
271 SYSTEMIC INFECTION 3 0.0018
272 RETROPERITONEAL HAEMATOMA 4 0.0018
273 VASCULITIS 21 0.0018
274 RHINOVIRUS INFECTION 7 0.0018
275 MENINGITIS TUBERCULOUS 1 0.0018
276 LEGIONELLA INFECTION 1 0.0017
277 CARDIORENAL SYNDROME 1 0.0017
278 PELVIC ABSCESS 2 0.0017
279 VITAMIN B12 DECREASED 5 0.0017
280 HAEMATOMA INFECTION 1 0.0017
281 NEUROLOGICAL DECOMPENSATION 4 0.0017
282 MEDIASTINITIS 1 0.0017
283 AORTIC CALCIFICATION 1 0.0017
284 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
285 BONE MARROW TOXICITY 2 0.0017
286 BRAIN HERNIATION 5 0.0017
287 ESCHERICHIA TEST POSITIVE 2 0.0017
288 SUBCUTANEOUS ABSCESS 8 0.0017
289 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
290 BRAIN OEDEMA 21 0.0017
291 BACTERIAL INFECTION 31 0.0017
292 CATARACT SUBCAPSULAR 1 0.0016
293 ORAL MUCOSA EROSION 2 0.0016
294 CEREBRAL ASPERGILLOSIS 1 0.0016
295 VENOOCCLUSIVE LIVER DISEASE 8 0.0016
296 POST-ACUTE COVID-19 SYNDROME 2 0.0016
297 BLOOD CREATININE DECREASED 5 0.0016
298 DRY GANGRENE 1 0.0016
299 APGAR SCORE LOW 2 0.0016
300 BILIARY OBSTRUCTION 2 0.0015
301 BACTERIAL SEPSIS 5 0.0015
302 ASPERGILLOSIS 2 0.0015
303 ANISOCYTOSIS 1 0.0015
304 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 9 0.0015
305 OESOPHAGEAL HAEMORRHAGE 2 0.0015
306 ILEAL PERFORATION 1 0.0015
307 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
308 FUNGAL SKIN INFECTION 6 0.0015
309 CYST RUPTURE 1 0.0015
310 INFECTIOUS PERITONITIS 1 0.0015
311 HEPATIC CYST 5 0.0015
312 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
313 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
314 NECROTISING FASCIITIS 5 0.0014
315 INFUSION SITE INFLAMMATION 1 0.0014
316 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
317 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
318 DELAYED GRAFT FUNCTION 1 0.0014
319 STEVENS-JOHNSON SYNDROME 31 0.0014
320 DYSPNOEA AT REST 4 0.0014
321 ESCHERICHIA SEPSIS 4 0.0014
322 HYPOGAMMAGLOBULINAEMIA 9 0.0014
323 FINGER AMPUTATION 1 0.0014
324 CACHEXIA 7 0.0014
325 HYPERBILIRUBINAEMIA 14 0.0014
326 HYPERTHERMIA MALIGNANT 2 0.0013
327 EOSINOPHIL COUNT ABNORMAL 1 0.0013
328 DISSEMINATED CRYPTOCOCCOSIS 1 0.0013
329 BRONCHITIS BACTERIAL 1 0.0013
330 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
331 PNEUMONIA BACTERIAL 12 0.0013
332 OLIGURIA 8 0.0013
333 IMPLANT SITE EXTRAVASATION 1 0.0013
334 LABORATORY TEST INTERFERENCE 1 0.0013
335 AORTIC DISORDER 1 0.0013
336 LONG QT SYNDROME 3 0.0013
337 EROSIVE DUODENITIS 1 0.0013
338 HAEMOPERITONEUM 1 0.0012
339 CRYPTOCOCCOSIS 2 0.0012
340 ARTHRITIS BACTERIAL 5 0.0012
341 FUNGAL INFECTION 40 0.0012
342 CULTURE POSITIVE 1 0.0012
343 BK VIRUS INFECTION 4 0.0012
344 BLOOD CHLORIDE INCREASED 2 0.0012
345 CYTOKINE RELEASE SYNDROME 23 0.0011
346 MENINGITIS CRYPTOCOCCAL 2 0.0011
347 DIVERTICULUM INTESTINAL 5 0.0011
348 ABDOMINAL SEPSIS 1 0.0011
349 GENERALISED OEDEMA 14 0.0011
350 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
351 CONTRAINDICATED PRODUCT ADMINISTERED 34 0.0011
352 SOFT TISSUE INFECTION 2 0.0011
353 CALCIPHYLAXIS 2 0.0011
354 DRUG LEVEL DECREASED 11 0.0011
355 HEMIPARESIS 18 0.0011
356 SEPSIS 118 0.0011
357 MULTI-ORGAN FAILURE 18 0.0010
358 STRESS CARDIOMYOPATHY 6 0.0010
359 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
360 HYPOCOAGULABLE STATE 1 0.0010
361 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
362 INCORRECT DOSAGE ADMINISTERED 5 0.0010
363 HAEMOPHILUS INFECTION 1 0.0010
364 DUODENAL PERFORATION 1 0.0010
365 DEVICE RELATED THROMBOSIS 1 0.0010
366 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
367 HYPOFIBRINOGENAEMIA 1 0.0010
368 INFLAMMATORY MARKER INCREASED 5 0.0010
369 BLOOD ALBUMIN DECREASED 8 0.0010
370 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
371 BRAIN HYPOXIA 1 0.0010
372 LYMPHOCYTIC INFILTRATION 1 0.0010
373 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
374 HYPOTHERMIA 10 0.0010
375 NEUTROPENIC SEPSIS 7 0.0010
376 BRAIN STEM INFARCTION 1 0.0010
377 PERIPHERAL ISCHAEMIA 4 0.0010
378 ENDOCARDITIS 5 0.0010
379 CHOLANGITIS SCLEROSING 2 0.0010
380 DIVERTICULAR PERFORATION 2 0.0010
381 HEART TRANSPLANT REJECTION 1 0.0010
382 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
383 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
384 SERUM FERRITIN INCREASED 5 0.0009
385 SPLENOMEGALY 11 0.0009
386 ATELECTASIS 9 0.0009
387 CARDIAC AMYLOIDOSIS 1 0.0009
388 NOSOCOMIAL INFECTION 2 0.0009
389 COAGULOPATHY 15 0.0009
390 BACTERIAL TEST POSITIVE 2 0.0009
391 PANCYTOPENIA 50 0.0009
392 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
393 RESPIRATORY FAILURE 65 0.0009
394 VASCULAR DEVICE INFECTION 4 0.0009
395 METABOLIC ACIDOSIS 28 0.0009
396 INFECTION REACTIVATION 1 0.0009
397 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
398 PANCREATITIS NECROTISING 2 0.0009
399 CARBON DIOXIDE DECREASED 1 0.0009
400 METHAEMOGLOBINAEMIA 2 0.0009
401 LARGE INTESTINE PERFORATION 6 0.0009
402 DECUBITUS ULCER 7 0.0009
403 ABNORMAL FAECES 7 0.0009
404 HEPATOTOXICITY 19 0.0009
405 ACUTE LUNG INJURY 1 0.0008
406 PROTHROMBIN TIME PROLONGED 5 0.0008
407 BILE DUCT STENOSIS 1 0.0008
408 NERVOUS SYSTEM DISORDER 26 0.0008
409 EMBOLISM ARTERIAL 1 0.0008
410 DIABETES INSIPIDUS 2 0.0008
411 HEPATITIS CHOLESTATIC 5 0.0008
412 SHOCK 19 0.0008
413 LYMPHADENITIS 2 0.0008
414 PNEUMOTHORAX 13 0.0008
415 EJECTION FRACTION ABNORMAL 1 0.0008
416 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
417 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
418 ACUTE HEPATIC FAILURE 11 0.0008
419 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
420 HYDRONEPHROSIS 6 0.0008
421 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
422 HEPATIC FAILURE 24 0.0008
423 IATROGENIC INJURY 1 0.0008
424 ABDOMINAL OPERATION 1 0.0008
425 HEPATITIS TOXIC 2 0.0008
426 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
427 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
428 BLOOD LACTIC ACID INCREASED 4 0.0008
429 HERPES OPHTHALMIC 1 0.0008
430 INTESTINAL DILATATION 1 0.0007
431 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
432 FEBRILE NEUTROPENIA 49 0.0007
433 LIP BLISTER 2 0.0007
434 BLOOD PHOSPHORUS INCREASED 2 0.0007
435 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
436 INFUSION SITE RASH 1 0.0007
437 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
438 BILIARY TRACT DISORDER 1 0.0007
439 DISCHARGE 1 0.0007
440 NECROSIS 4 0.0007
441 ORAL HERPES 14 0.0007
442 BLOOD UREA INCREASED 12 0.0007
443 ENDOTRACHEAL INTUBATION 2 0.0007
444 NEPHROPATHY TOXIC 8 0.0007
445 H1N1 INFLUENZA 1 0.0007
446 CULTURE URINE POSITIVE 1 0.0007
447 NEUTROPHIL COUNT ABNORMAL 2 0.0007
448 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
449 OESOPHAGEAL STENOSIS 2 0.0007
450 LEUKOPENIA 35 0.0007
451 MENINGITIS BACTERIAL 1 0.0007
452 ENTEROCOLITIS 4 0.0007
453 DERMATITIS BULLOUS 5 0.0007
454 GASTROINTESTINAL NECROSIS 2 0.0007
455 HYPOVOLAEMIA 4 0.0007
456 GASTROINTESTINAL WALL THICKENING 1 0.0007
457 BLOOD CULTURE POSITIVE 2 0.0007
458 HYPERCAPNIA 2 0.0007
459 ADHESION 1 0.0007
460 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
461 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
462 ACUTE GRAFT VERSUS HOST DISEASE 3 0.0007
463 PULMONARY HAEMORRHAGE 5 0.0006
464 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
465 RENAL CYST 5 0.0006
466 NEUTROPENIA 85 0.0006
467 VENTRICULAR HYPOKINESIA 2 0.0006
468 BLOOD CALCIUM DECREASED 7 0.0006
469 RASH VESICULAR 3 0.0006
470 PORTAL VEIN THROMBOSIS 2 0.0006
471 HERPES SIMPLEX 4 0.0006
472 RESPIRATORY TRACT INFECTION 16 0.0006
473 SHOCK HAEMORRHAGIC 5 0.0006
474 PLATELET COUNT INCREASED 8 0.0006
475 LYMPHOCYTE COUNT INCREASED 2 0.0006
476 HAEMOPTYSIS 17 0.0006
477 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
478 CYTOMEGALOVIRUS INFECTION 10 0.0006
479 NEPHRITIS 2 0.0006
480 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
481 CEREBELLAR INFARCTION 1 0.0006
482 B-CELL LYMPHOMA 2 0.0006
483 CIRCULATORY COLLAPSE 10 0.0006
484 LIVER FUNCTION TEST ABNORMAL 17 0.0006
485 PERITONITIS 12 0.0006
486 FOETAL DEATH 3 0.0006
487 GRANULOMA 2 0.0006
488 HYPERREFLEXIA 2 0.0006
489 EXTREMITY NECROSIS 1 0.0006
490 NEUROTOXICITY 10 0.0006
491 DRUG SCREEN NEGATIVE 1 0.0006
492 HALLUCINATION, VISUAL 12 0.0006
493 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
494 HISTOPLASMOSIS 1 0.0006
495 ILEAL STENOSIS 1 0.0006
496 FIBRIN D DIMER INCREASED 2 0.0006
497 JUGULAR VEIN THROMBOSIS 1 0.0006
498 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
499 LIVER TRANSPLANT REJECTION 1 0.0006
500 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
501 C-REACTIVE PROTEIN INCREASED 20 0.0005
502 OVARIAN CANCER 5 0.0005
503 IRON DEFICIENCY ANAEMIA 5 0.0005
504 BLOOD PRESSURE FLUCTUATION 13 0.0005
505 HYPOXIA 19 0.0005
506 BLOOD CHOLESTEROL DECREASED 1 0.0005
507 STATUS EPILEPTICUS 6 0.0005
508 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
509 SPINAL DISORDER 5 0.0005
510 MYELOSUPPRESSION 19 0.0005
511 BILE DUCT OBSTRUCTION 1 0.0005
512 COMMUNICATION DISORDER 2 0.0005
513 OESOPHAGEAL ULCER 2 0.0005
514 RENAL FAILURE 69 0.0005
515 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
516 STAPHYLOCOCCAL INFECTION 17 0.0005
517 TACHYPNOEA 7 0.0005
518 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
519 THROMBOCYTOPENIA 57 0.0005
520 DRUG ERUPTION 9 0.0005
521 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
522 GENE MUTATION 1 0.0005
523 HAEMATOCRIT DECREASED 10 0.0005
524 CELL DEATH 1 0.0005
525 EMPYEMA 1 0.0005
526 RASH ERYTHEMATOUS 24 0.0005
527 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
528 ABSCESS 8 0.0005
529 ENDOPHTHALMITIS 3 0.0005
530 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
531 BRAIN INJURY 5 0.0005
532 AKINESIA 1 0.0005
533 LIVEDO RETICULARIS 1 0.0005
534 LUNG ABSCESS 1 0.0005
535 INCONTINENCE 5 0.0005
536 PULMONARY TUBERCULOSIS 2 0.0005
537 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
538 HYPERPHOSPHATAEMIA 1 0.0005
539 MYOPATHY 4 0.0005
540 HEPATITIS ACUTE 3 0.0005
541 PRODUCT PRESCRIBING ISSUE 10 0.0005
542 PULMONARY CONGESTION 6 0.0005
543 DEVICE RELATED INFECTION 7 0.0005
544 DIABETIC NEPHROPATHY 1 0.0005
545 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
546 CLOSTRIDIUM TEST POSITIVE 1 0.0005
547 IMMUNOSUPPRESSION 4 0.0005
548 LYMPHOMA 7 0.0005
549 CHOLESTATIC LIVER INJURY 1 0.0004
550 ILEUS PARALYTIC 2 0.0004
551 MALNUTRITION 5 0.0004
552 INTESTINAL PERFORATION 5 0.0004
553 LEUKOCYTOSIS 8 0.0004
554 DISTRIBUTIVE SHOCK 1 0.0004
555 HALLUCINATION, AUDITORY 7 0.0004
556 CYTOMEGALOVIRUS COLITIS 1 0.0004
557 LACTIC ACIDOSIS 14 0.0004
558 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
559 HYPERTRANSAMINASAEMIA 3 0.0004
560 AGRANULOCYTOSIS 8 0.0004
561 BILIRUBIN CONJUGATED INCREASED 1 0.0004
562 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
563 ATAXIA 5 0.0004
564 EOSINOPHIL COUNT DECREASED 1 0.0004
565 POLYNEUROPATHY 5 0.0004
566 RENAL IMPAIRMENT 35 0.0004
567 NOCTURIA 5 0.0004
568 PLEURAL EFFUSION 25 0.0004
569 BLOOD BILIRUBIN INCREASED 11 0.0004
570 STAPHYLOCOCCAL SEPSIS 2 0.0004
571 ORGANISING PNEUMONIA 2 0.0004
572 DELIRIUM 14 0.0004
573 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
574 HYPERNATRAEMIA 2 0.0004
575 CATHETER SITE HAEMORRHAGE 1 0.0004
576 ERYSIPELAS 2 0.0004
577 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
578 CEREBRAL ISCHAEMIA 2 0.0004
579 PARTIAL SEIZURES 2 0.0004
580 DISEASE PROGRESSION 45 0.0004
581 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
582 HEPATIC FUNCTION ABNORMAL 14 0.0004
583 ACUTE KIDNEY INJURY 57 0.0004
584 GASTROINTESTINAL INJURY 1 0.0004
585 HYPERKALAEMIA 13 0.0004
586 ESCHERICHIA INFECTION 3 0.0004
587 CHOLESTASIS 7 0.0004
588 DRUG LEVEL INCREASED 6 0.0004
589 INTRACRANIAL PRESSURE INCREASED 2 0.0004
590 COORDINATION ABNORMAL 5 0.0004
591 ACUTE PULMONARY OEDEMA 2 0.0004
592 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
593 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
594 DUODENAL ULCER HAEMORRHAGE 1 0.0003
595 HEART VALVE INCOMPETENCE 1 0.0003
596 MYOCARDITIS 4 0.0003
597 HERPES VIRUS INFECTION 2 0.0003
598 EYELID MARGIN CRUSTING 1 0.0003
599 COMA SCALE ABNORMAL 1 0.0003
600 ADENOVIRUS INFECTION 1 0.0003
601 FLUID OVERLOAD 5 0.0003
602 BODY TEMPERATURE INCREASED 7 0.0003
603 RESPIRATORY RATE INCREASED 3 0.0003
604 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
605 ATYPICAL PNEUMONIA 1 0.0003
606 APHASIA 10 0.0003
607 RENAL FAILURE ACUTE 14 0.0003
608 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
609 CYTOPENIA 4 0.0003
610 CHOLANGITIS 2 0.0003
611 INFUSION SITE EXTRAVASATION 2 0.0003
612 ACUTE MYELOID LEUKAEMIA 5 0.0003
613 MELAENA 7 0.0003
614 ENTERITIS 2 0.0003
615 ACUTE RESPIRATORY FAILURE 6 0.0003
616 INTERSTITIAL LUNG DISEASE 15 0.0003
617 DRUG INTERACTION 49 0.0003
618 THROMBOTIC MICROANGIOPATHY 3 0.0003
619 IMPAIRED HEALING 10 0.0003
620 ORAL CANDIDIASIS 4 0.0003
621 HYPOKALAEMIA 14 0.0003
622 VENTRICULAR TACHYCARDIA 5 0.0003
623 PERICARDIAL EFFUSION 7 0.0003
624 RESPIRATORY DISORDER 9 0.0003
625 CARDIAC FAILURE ACUTE 2 0.0003
626 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
627 DRUG INEFFECTIVE 393 0.0003
628 PERITONITIS BACTERIAL 3 0.0003
629 CLOSTRIDIAL INFECTION 1 0.0003
630 SKIN LESION 8 0.0003
631 PNEUMONIA 94 0.0003
632 HYPOTENSION 58 0.0003
633 AORTIC STENOSIS 1 0.0003
634 OXYGEN SATURATION DECREASED 16 0.0003
635 EMBOLIC STROKE 1 0.0003
636 JAUNDICE CHOLESTATIC 1 0.0003
637 RED BLOOD CELL COUNT DECREASED 8 0.0003
638 CARDIOGENIC SHOCK 4 0.0003
639 CELLULITIS 14 0.0003
640 HAEMATEMESIS 7 0.0003
641 HYPOKINESIA 4 0.0003
642 HEPATITIS 7 0.0003
643 ASCITES 8 0.0003
644 HYPOPHOSPHATAEMIA 2 0.0003
645 CARDIAC DYSFUNCTION 1 0.0003
646 HAEMORRHAGE INTRACRANIAL 4 0.0003
647 PYREXIA 92 0.0003
648 TREATMENT FAILURE 22 0.0003
649 CATHETER SITE INFECTION 1 0.0003
650 HEPATIC ENZYME INCREASED 18 0.0003
651 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
652 EPILEPSY 8 0.0003
653 ACIDOSIS 2 0.0003
654 LIPASE INCREASED 2 0.0003
655 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
656 JAUNDICE 7 0.0003
657 CYANOSIS 4 0.0003
658 LOW BIRTH WEIGHT BABY 2 0.0003
659 CEREBRAL HAEMORRHAGE 9 0.0003
660 PREMATURE DELIVERY 4 0.0003
661 CEREBRAL ATROPHY 1 0.0003
662 AZOTAEMIA 1 0.0003
663 TRANSPLANT REJECTION 2 0.0002
664 CANDIDIASIS 1 0.0002
665 INTRACRANIAL ANEURYSM 1 0.0002
666 EXTRAVASATION 1 0.0002
667 INFECTION 35 0.0002
668 ILEUS 3 0.0002
669 HEMIPLEGIA 2 0.0002
670 ACCIDENTAL EXPOSURE 1 0.0002
671 LABORATORY TEST ABNORMAL 7 0.0002
672 ANAEMIA 45 0.0002
673 AORTIC VALVE INCOMPETENCE 1 0.0002
674 ABSCESS LIMB 1 0.0002
675 DEEP VEIN THROMBOSIS 15 0.0002
676 SKIN SWELLING 2 0.0002
677 CONDITION AGGRAVATED 70 0.0002
678 MUCOSAL INFLAMMATION 6 0.0002
679 TUMOUR LYSIS SYNDROME 2 0.0002
680 LUNG INFILTRATION 2 0.0002
681 LIGAMENT RUPTURE 1 0.0002
682 BLOOD CREATINE INCREASED 1 0.0002
683 TRANSAMINASES INCREASED 5 0.0002
684 CARDIOTOXICITY 2 0.0002
685 IRON DEFICIENCY 1 0.0002
686 PNEUMONITIS 6 0.0002
687 DRUG TOXICITY 3 0.0002
688 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
689 IMPAIRED GASTRIC EMPTYING 3 0.0002
690 DISEASE COMPLICATION 1 0.0002
691 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
692 CARDIAC ARREST 18 0.0002
693 ISCHAEMIA 1 0.0002
694 RESPIRATORY DISTRESS 6 0.0002
695 UROSEPSIS 2 0.0002
696 LOCALISED OEDEMA 1 0.0002
697 MENTAL STATUS CHANGES 6 0.0002
698 ARTHRITIS INFECTIVE 1 0.0002
699 BLOOD CREATININE INCREASED 14 0.0002
700 OFF LABEL USE 187 0.0002
701 HYPONATRAEMIA 12 0.0002
702 CARDIAC TAMPONADE 1 0.0002
703 BRONCHOSPASM 3 0.0002
704 DISEASE RECURRENCE 10 0.0002
705 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
706 HYPOVOLAEMIC SHOCK 1 0.0002
707 KIDNEY TRANSPLANT REJECTION 1 0.0002
708 GUILLAIN-BARRE SYNDROME 1 0.0002
709 ENCEPHALOPATHY 5 0.0002
710 HYPERVOLAEMIA 1 0.0002
711 PULMONARY MASS 3 0.0002
712 HYPERAMMONAEMIA 1 0.0002
713 PULMONARY EMBOLISM 19 0.0002
714 BLOOD POTASSIUM DECREASED 6 0.0002
715 CORONARY ARTERY STENOSIS 1 0.0002
716 LACRIMATION INCREASED 6 0.0002
717 NEUTROPHIL COUNT INCREASED 2 0.0002
718 ATRIAL FIBRILLATION 19 0.0002
719 FEMORAL NECK FRACTURE 1 0.0002
720 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
721 ANKLE FRACTURE 3 0.0002
722 SKIN ULCER 5 0.0002
723 LUNG INFECTION 3 0.0002
724 APLASTIC ANAEMIA 1 0.0002
725 RENAL PAIN 2 0.0002
726 ANAL FISTULA 1 0.0002
727 ANAL ABSCESS 1 0.0002
728 BLOOD POTASSIUM INCREASED 3 0.0002
729 HYDROCEPHALUS 1 0.0002
730 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
731 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
732 PROCEDURAL PAIN 5 0.0002
733 RASH MACULO-PAPULAR 4 0.0002
734 THERAPY NON-RESPONDER 8 0.0002
735 FISTULA 2 0.0002
736 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
737 FLUID RETENTION 9 0.0002
738 GENERALISED ERYTHEMA 1 0.0002
739 MYOCARDIAL ISCHAEMIA 2 0.0002
740 GRANULOCYTOPENIA 1 0.0002
741 SCAB 2 0.0002
742 CARDIAC VALVE DISEASE 1 0.0002
743 THROMBOSIS 14 0.0002
744 BLOOD URIC ACID INCREASED 1 0.0002
745 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
746 ELECTROLYTE IMBALANCE 2 0.0002
747 POST PROCEDURAL HAEMORRHAGE 2 0.0002
748 CARDIOMEGALY 2 0.0002
749 HYPERCALCAEMIA 2 0.0002
750 HEPATIC STEATOSIS 3 0.0002
751 PNEUMONIA ASPIRATION 4 0.0002
752 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
753 HEPATIC CIRRHOSIS 3 0.0002
754 HEPATIC CYTOLYSIS 2 0.0002
755 INCOHERENT 1 0.0002
756 INFLUENZA 17 0.0002
757 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
758 BLOOD PRESSURE ABNORMAL 3 0.0002
759 MENINGITIS 1 0.0001
760 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
761 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
762 OEDEMA 8 0.0001
763 ECCHYMOSIS 1 0.0001
764 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
765 LIVER FUNCTION TEST INCREASED 3 0.0001
766 FAECES DISCOLOURED 3 0.0001
767 DYSURIA 5 0.0001
768 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
769 CARDIOMYOPATHY 2 0.0001
770 LIVER DISORDER 6 0.0001
771 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
772 CEREBRAL DISORDER 1 0.0001
773 PANCREATITIS ACUTE 3 0.0001
774 PREMATURE BABY 4 0.0001
775 DYSPNOEA EXERTIONAL 5 0.0001
776 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
777 HAEMOLYSIS 1 0.0001
778 ATRIOVENTRICULAR BLOCK 1 0.0001
779 HYPOALBUMINAEMIA 1 0.0001
780 HAEMORRHAGIC STROKE 1 0.0001
781 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
782 DRUG SCREEN POSITIVE 1 0.0001
783 ULCER 2 0.0001
784 TACHYCARDIA 11 0.0001
785 LIVER INJURY 3 0.0001
786 BLOOD PRESSURE DECREASED 8 0.0001
787 HAEMODIALYSIS 1 0.0001
788 INFUSION SITE ERYTHEMA 1 0.0001
789 HAEMOGLOBIN DECREASED 12 0.0001
790 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
791 CARDIAC OPERATION 1 0.0001
792 INFLAMMATION 6 0.0001
793 HAEMORRHAGE 12 0.0001
794 ARTHRITIS 9 0.0001
795 EOSINOPHILIA 2 0.0001
796 PANCREATITIS 6 0.0001
797 LYMPHOCYTE COUNT DECREASED 2 0.0001
798 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
799 CARDIAC FAILURE 9 0.0001
800 RESPIRATORY ARREST 3 0.0001
801 HEPATIC ENCEPHALOPATHY 1 0.0001
802 FLANK PAIN 1 0.0001
803 ARTERIOSCLEROSIS 1 0.0001
804 BLOOD SODIUM DECREASED 2 0.0001
805 HAEMATOTOXICITY 1 0.0001
806 CONFUSIONAL STATE 17 0.0001
807 CONVULSION 6 0.0001
808 SEROTONIN SYNDROME 2 0.0001
809 COVID-19 18 0.0001
810 KIDNEY INFECTION 2 0.0001
811 HEPATOMEGALY 1 0.0001
812 ILL-DEFINED DISORDER 6 0.0001
813 NEUTROPHIL COUNT DECREASED 4 0.0001
814 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
815 RHABDOMYOLYSIS 4 0.0001
816 BRADYCARDIA 5 0.0001
817 EPISTAXIS 7 0.0001
818 DEATH 80 0.0001
819 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
820 ASPIRATION 1 0.0001
821 ANAPHYLACTIC REACTION 5 0.0001
822 DENTAL CARIES 1 0.0001
823 TOOTH DISORDER 2 0.0001
824 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
825 PULMONARY OEDEMA 4 0.0001
826 COUGH 25 0.0001
827 HEART RATE IRREGULAR 2 0.0001
828 DERMATITIS CONTACT 1 0.0001
829 LETHARGY 5 0.0001
830 RENAL DISORDER 4 0.0001
831 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
832 LYMPHADENOPATHY 3 0.0001
833 PRODUCTIVE COUGH 4 0.0001
834 MACULAR DEGENERATION 1 0.0001
835 HEPATITIS C 1 0.0001
836 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
837 BALANCE DISORDER 7 0.0001
838 COLITIS 3 0.0001
839 INFUSION SITE PAIN 1 0.0001
840 ANAPHYLACTIC SHOCK 2 0.0001
841 GASTRITIS 2 0.0001
842 PLATELET COUNT DECREASED 8 0.0001
843 DIARRHOEA 48 0.0001
844 PALLOR 2 0.0001
845 ERYTHEMA 15 0.0001
846 HYPOMAGNESAEMIA 1 0.0001
847 LYMPHOPENIA 1 0.0001
848 DIALYSIS 1 0.0001
849 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
850 MOBILITY DECREASED 5 0.0001
851 SEIZURE 8 0.0001
852 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
853 ABDOMINAL PAIN 16 0.0001
854 GASTROENTERITIS 1 0.0001
855 AGITATION 5 0.0001
856 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
857 ACUTE MYOCARDIAL INFARCTION 2 0.0001
858 RENAL INJURY 2 0.0001
859 IMMUNODEFICIENCY 1 0.0001
860 GASTROINTESTINAL DISORDER 6 0.0001
861 HYPOAESTHESIA ORAL 1 0.0001
862 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
863 SOMNOLENCE 13 0.0001
864 DELUSION 1 0.0001
865 EJECTION FRACTION DECREASED 1 0.0001
866 SWOLLEN TONGUE 2 0.0001
867 DRUG-INDUCED LIVER INJURY 2 0.0001
868 DYSPNOEA 36 0.0001
869 ARRHYTHMIA 3 0.0001
870 VOMITING 29 0.0001
871 ASTHENIA 23 0.0001
872 FACE OEDEMA 1 0.0001
873 SKIN EXFOLIATION 5 0.0001
874 PRODUCT USE ISSUE 11 0.0001
875 RASH MACULAR 2 0.0001
876 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
877 HEART RATE DECREASED 2 0.0001
878 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
879 ISCHAEMIC STROKE 1 0.0001
880 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
881 END STAGE RENAL DISEASE 1 0.0001
882 RESTLESSNESS 2 0.0001
883 HYPOAESTHESIA 8 0.0001
884 BLISTER 3 0.0001
885 HYPOCALCAEMIA 1 0.0001
886 GASTRIC ULCER 1 0.0001
887 DYSTONIA 1 0.0001
888 EAR PAIN 1 0.0001
889 DISORIENTATION 2 0.0001
890 HEART RATE INCREASED 5 0.0001
891 NO ADVERSE EVENT 9 0.0000
892 STOMATITIS 3 0.0000
893 BONE MARROW FAILURE 1 0.0000
894 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
895 TREMOR 8 0.0000
896 TOXICITY TO VARIOUS AGENTS 8 0.0000
897 URINARY TRACT INFECTION 8 0.0000
898 WEIGHT DECREASED 13 0.0000
899 SWELLING FACE 3 0.0000
900 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
901 SKIN IRRITATION 2 0.0000
902 ADVERSE EVENT 4 0.0000
903 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
904 HYPERTENSION 9 0.0000
905 BLOOD GLUCOSE DECREASED 2 0.0000
906 DIABETIC KETOACIDOSIS 1 0.0000
907 HYPOGLYCAEMIA 2 0.0000
908 HALLUCINATION 3 0.0000
909 HYPOPHAGIA 1 0.0000
910 RASH 17 0.0000
911 CHEST PAIN 7 0.0000
912 DEHYDRATION 5 0.0000
913 OVERDOSE 8 0.0000
914 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
915 MEDICATION ERROR 2 0.0000
916 HERPES ZOSTER 2 0.0000
917 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
918 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
919 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
920 THERAPEUTIC RESPONSE DECREASED 2 0.0000
921 DRUG ADMINISTRATION ERROR 1 0.0000
922 FEMUR FRACTURE 1 0.0000
923 CARDIAC DISORDER 3 0.0000
924 BLOOD GLUCOSE INCREASED 6 0.0000
925 DRUG INTOLERANCE 3 0.0000
926 CHOLELITHIASIS 1 0.0000
927 EYE DISORDER 1 0.0000
928 INFUSION RELATED REACTION 2 0.0000
929 ILLNESS 3 0.0000
930 BURNING SENSATION 2 0.0000
931 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
932 CRYING 1 0.0000
933 CONSTIPATION 6 0.0000
934 MUSCLE SPASMS 5 0.0000
935 BRONCHITIS 2 0.0000
936 HYPERSENSITIVITY 5 0.0000
937 EYE SWELLING 1 0.0000
938 CHRONIC KIDNEY DISEASE 2 0.0000
939 BLOOD PRESSURE INCREASED 4 0.0000
940 PALPITATIONS 3 0.0000
941 CHILLS 3 0.0000
942 NAUSEA 20 0.0000
943 ABNORMAL BEHAVIOUR 1 0.0000
944 CARDIAC FAILURE CONGESTIVE 2 0.0000
945 DYSKINESIA 1 0.0000
946 ABDOMINAL PAIN UPPER 5 0.0000
947 VISUAL IMPAIRMENT 3 0.0000
948 FALL 8 0.0000
949 CARDIO-RESPIRATORY ARREST 1 0.0000
950 INTENTIONAL PRODUCT MISUSE 2 0.0000
951 COLITIS ULCERATIVE 1 0.0000
952 SWELLING 2 0.0000
953 COMA 1 0.0000
954 LUNG DISORDER 1 0.0000
955 AGGRESSION 1 0.0000
956 CHEST DISCOMFORT 2 0.0000
957 DRUG EFFECT DECREASED 1 0.0000
958 PRURITUS 7 0.0000
959 HAEMATOCHEZIA 1 0.0000
960 ARTHROPATHY 1 0.0000
961 DECREASED APPETITE 4 0.0000
962 BONE PAIN 1 0.0000
963 PAIN IN EXTREMITY 5 0.0000
964 CATARACT 1 0.0000
965 FATIGUE 13 0.0000
966 OEDEMA PERIPHERAL 2 0.0000
967 FEELING HOT 1 0.0000
968 EXPOSURE DURING PREGNANCY 1 0.0000
969 HEADACHE 10 0.0000
970 INTENTIONAL OVERDOSE 1 0.0000
971 HYPERHIDROSIS 2 0.0000
972 ALOPECIA 3 0.0000
973 INSOMNIA 4 0.0000
974 PRODUCT QUALITY ISSUE 2 0.0000
975 INJECTION SITE REACTION 1 0.0000
976 INCORRECT DOSE ADMINISTERED 3 0.0000
977 DIABETES MELLITUS 1 0.0000
978 BACK PAIN 3 0.0000
979 INFLUENZA LIKE ILLNESS 1 0.0000
980 CEREBROVASCULAR ACCIDENT 2 0.0000
981 ANXIETY 3 0.0000
982 DYSPHAGIA 1 0.0000
983 GAIT DISTURBANCE 2 0.0000
984 FLUSHING 1 0.0000
985 MALAISE 3 0.0000
986 PRODUCT DOSE OMISSION ISSUE 2 0.0000
987 HOSPITALISATION 1 0.0000
988 DRUG DEPENDENCE 1 0.0000
989 DRUG DOSE OMISSION 1 0.0000
990 ABDOMINAL DISCOMFORT 1 0.0000
991 DEPRESSION 1 0.0000
992 ARTHRALGIA 1 0.0000